Skip to content

IPHA - The Value of Health and Medicines Innovation For Society

to
We look forward to welcoming you at 8am on the 27th of October, 2020, for the fourth event in the IPHA Digital ThinkIn Series, sponsored by Uniphar.

This event, in partnership with the WifOR Economic Research Institute, explores how medicines innovation benefits societies and economies. And we examine the link between wealth and health, showing how healthcare is increasingly considered an investment rather than a cost. As well as hearing from the experts, you will have the opportunity to share your own perspectives and ask questions.

For more information, visit https://www.ipha.ie/ 

Schedule

· Stage
Oliver O'Connor CEO, IPHA
Opening and introduction of speakers
· Stage
Professor Zaza Katsarava, Chief of Department of Neurology, Evangelical Hospital Unna, Germany; President of European Headache Federation
Topic: Epidemiological perspectives on migraines including burden of disease and quality of care
· Stage
Professor Dennis A. Ostwald, Founder and CEO, WifOR Institute
Topic (part I):Socio-economic burden of migraines and value (societal impact) of migraine medication in Germany
Dennis A. Ostwald
· Stage
Professor Dennis A. Ostwald, Founder and CEO, WifOR Institute
Topic (part II): Burden of selected diseases in Ireland and societal value created by medicines innovation
Dennis A. Ostwald
· Stage
Alan Donnelly, Executive Chairman of Sovereign Strategy; Patron of G20 Health & Development Partnership
Topic: Policy tools and implications of health investments
Alan Donnelly
· Stage
Q&A / Discussion amongst panelists
Discussion moderated by Oliver O'Connor CEO, IPHA

Speakers

Alan Donnelly

Executive Chairman of Sovereign Strategy; Patron of G20 Health & Development Partnership

Dennis A. Ostwald

Founder and CEO, WifOR Institute

Tickets

Already registered? Log In to access the event
Hosted by

Virtual Events

Share on

Booths

Uniphar

Product Access

IPHA

#innovateforlife